Genoskin wishes you a successful 2018!

11 January 2018 By Genoskin Comments are Off

Comments are closed.

Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.

CONTACT INFO EUROPE

+33 972 476 029

contact@genoskin.com

1, Place Pierre Potier
31100 Toulouse, France

CONTACT INFO USA

+ 1 (617)-416-5358

contact@genoskin.com

4 Technology way
Salem, MA 01970, USA

DON’T MISS OUR LATEST NEWS!

FOLLOW US!

On LinkedIn

On Twitter

LATEST NEWS

Genoskin launches ISR platform, first platform to test injections sites reactions ahead of clinical trials

Genoskin launches the ISR platform®

6 July 2021

Top advantages of NativeSkin access vs sourcing skin directly from hospitals

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

15 June 2021

Injection site reactions are common upon subcutaneous injection of biologics. Genoskin support drug development by offering a new platform of services dedicated to this specific adverse effect

Injection site reactions platform

10 June 2021

Quote from Guy Serre for Genoskin's 10 Year anniversary

Interview with Pr. Guy Serre

9 June 2021

Using NativeSkin® to study poison ivy-induced dermatitis

22 February 2021